International Journal of Homoeopathic Sciences
Vol. 6, Issue 3, Part B (2022)
Evaluation of a homoeopathic therapeutic strategy involving tuberculinum, zincum metallicum, Chininum arsenicosum and calcarea phos in prophylaxis of COVID-19
Author(s):
Dr. Dilip B Dikshit, Dr. MK Kamath, Dr. Navin Pawaskar, Dr. Reshel Noronha, Dr. Rajachandra G, Dr. Shwetha Bhat and Dr. Anjali Chodnekar
Abstract:
Background: In March 2020, WHO declared the COVID-19 outbreak as a pandemic. Preventive strategies have been explored by a large number of researchers. Zincum Metallicum and China Ars are known to prevent replication of the virus. A use of nosodes Tuberculinum enhances the action of these components used in the formulation.
Methods: The study is an open-label randomized controlled trial evaluating the immune boosting ability of a Homoeopathic therapeutic strategy involving a nosodes Tuberculinum 1M, followed by Zincum Metallicum 6c, Chininum arsenicosum 6c and Calcarea Phos 6x in asymptomatic Novel coronavirus disease (COVID-19 ) in vulnerable risk group.
Results: A statistically significant effect was observed in the strata of age group of 21-30 in terms of completion of treatment (p< 0.001). Among the occupation, the health professionals group showed statistically significant results with respect to completion of the treatment (p< 0.001). There were no variation statistically significant results observed in terms of other factors.
Conclusions: Homoeopathic therapeutic strategy involving a nosodes Tuberculinum 1M, followed by Zincum Metallicum 6c, Chininum arsenicosum 6c and Calcarea Phos 6x is effective in age groups 21-30 years. A larger trial may be carried out based on the results of the current study.
Pages: 85-90 | 1558 Views 713 Downloads
How to cite this article:
Dr. Dilip B Dikshit, Dr. MK Kamath, Dr. Navin Pawaskar, Dr. Reshel Noronha, Dr. Rajachandra G, Dr. Shwetha Bhat and Dr. Anjali Chodnekar. Evaluation of a homoeopathic therapeutic strategy involving tuberculinum, zincum metallicum, Chininum arsenicosum and calcarea phos in prophylaxis of COVID-19. Int. J. Hom. Sci. 2022;6(3):85-90. DOI: https://doi.org/10.33545/26164485.2022.v6.i3b.602
